Skip to main content
SpringerLink
Log in
Book cover

Therapie der Hautkrankheiten pp 611–620Cite as

Mastzellkrankheiten

  • Chapter

  • 224 Accesses

Zusammenfassung

Mastzellen kommen regelmäßig im subpapillären Raum der Haut perivaskulär und um die epithelialen Anhangsgebilde (Haarwurzel, Talgdrüsen, Schweißdrüsen) vor. Von den inneren Organen sind z.B. die Lungen und das Peritoneum reich an Mastzellen. Sie besitzen eine Vielzahl biologisch aktiver Substanzen (Tabelle 26–1).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   378.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur zu Kapitel 26

  • Ashinoff R, Soter NA, Freedberg IM (1993) Solitary mastocytoma in an adult. Treatment by excision. J Dermatol Surg Oncol 19:487–488

    Article  PubMed  CAS  Google Scholar 

  • Butterfield JH (1998) Response of severe systemic mastocytosis to interferon alpha. Br J Dermatol 138:489–495

    Article  PubMed  CAS  Google Scholar 

  • Czarnetzki BM (1983) A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa. Dermatologica 166:44–47

    Article  PubMed  CAS  Google Scholar 

  • Czarnetzki BM, Rosenbach T, Kolde G, Frosch PJ (1985) Phototherapy of urticaria pigmentosa: clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes. Arch Dermatol Res 277:105–113

    Article  PubMed  CAS  Google Scholar 

  • Ellis DL (1996) Treatment of teleangiectasia macularis eruptiva perstans with the 585-nm flashlamp-pumped dye laser. Dermatol Surg 22:33–37

    PubMed  CAS  Google Scholar 

  • Emanuel PD, Barton JC, Gualtieri RJ, Sams WM (1991) Urticaria pigmentosa and preleukemia: evidence for reactive mast cell proliferation. J Am Acad Dermatol 24: 893–897

    Article  PubMed  CAS  Google Scholar 

  • Evans S, Vickers CFH (1981) Bullous urticaria pigmentosa (cutaneous mastocytosis) and sodium cromoglycate. Acta Derm Venereol 61:572–575

    PubMed  CAS  Google Scholar 

  • Fairley JA, Pentland AP, Voorhees JJ (1984) Urticaria pigmentosa responsive to nifedipine. J Am Acad Dermatol 11:740–743

    Article  PubMed  CAS  Google Scholar 

  • Fjellner B, Hägermark O (1982) Histamine release from rat peritoneal mast cells exposed to ultraviolet light. Acta Derm Venereol 62:215–220

    PubMed  CAS  Google Scholar 

  • Friedman B, Darling G, Norton J et al. (1990) Splenectomy in the management of systemic mast cell disease. Surgery 107:94–100

    PubMed  CAS  Google Scholar 

  • Friedman BS, Metcalfe DD (1991) Effects of tixocortol pivalate on gastrointestinal disease in systemic mastocytosis: a preliminary study. Clin Exp Allergy 21:183–188

    Article  PubMed  CAS  Google Scholar 

  • Garbe C, Rassner G (Hrsg) (1998) Dermatologie, Leitlinien und Qualitätssicherung für Diagnostik und Therapie: Berichte von der 39. Tagung der Deutschen Dermatologischen Gesellschaft. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Gasior-Chrzan B, Falk ES (1992) Systemic mastocytosis treated with histamine H1 and H2 receptor antagonists. Dermatology 184:149–152

    Article  PubMed  CAS  Google Scholar 

  • Godt O, Proksch E, Streit V, Christophers E (1997) Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis. Dermatology 195:35–39

    Article  PubMed  CAS  Google Scholar 

  • Granerus G, Roupe G, Swanbeck G (1981) Decreased urinary histamine metabolite after successful PUVA treatment of urticaria pigmentosa. J Invest Dermatol 76:1–3

    Article  PubMed  CAS  Google Scholar 

  • Guzzo C, Lavker R, Roberts LJ et al. (1991) Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids. Arch Dermatol 127:191–196

    Article  PubMed  CAS  Google Scholar 

  • Haase I, Grabbe J, Henz BM (1998) Urticaria pigmentosa und Mastozytose. Dtsch Med Wochenschr 123: 296–303

    Article  PubMed  CAS  Google Scholar 

  • Hagen W, Schwarmeier J, Walchshofer S et al. (1998) A case of bone marrow mastocytosis associated with multiple myeloma. Ann Hematol 76:167–174

    Article  PubMed  CAS  Google Scholar 

  • Haustein UF, Bedri M (1997) Bullöse Mastozytose bei einem Kind. Hautarzt 48:127–129

    Article  PubMed  CAS  Google Scholar 

  • Horan RF, Sheffer AL, Austen KF (1990) Cromolyn sodium in the management of systemic mastocytosis. J Allergy Clin Immunol 85: 852–855

    Article  PubMed  CAS  Google Scholar 

  • Horan RF, Schneider LC, Sheffer AL (1992) Allergic skin disorders and mastocytosis. JAMA 268:2858–2868

    Article  PubMed  CAS  Google Scholar 

  • Horny HP, Ruck M, Wehrmann M, Kaiserling E (1990) Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders. Br J Haematol 76:186–193

    Article  PubMed  CAS  Google Scholar 

  • Horny HP, Ruck MT, Kaiserling E (1992) Spleen findings in generalized mastocytosis. A clinicopathologic study. Cancer 70:459–468

    Article  PubMed  CAS  Google Scholar 

  • Husak R, Blume-Peytavi U, Pfrommer C et al. (2001) Nodular and bullous cutaneous mastocytosis of the xanthelasmoid type. Br J Dermatol 142:581–582

    Article  Google Scholar 

  • Jackson Roberts II L, Oates JA (1991) Pharmacological aspects of mast cell disease. J Invest Dermatol 96:19S–25S

    Article  Google Scholar 

  • Janjan NA, Conway P, Lundberg J, Derfus G (1992) Radiation therapy in a case of systemic mastocytosis: evaluation of histamine levels and mucosal effects. Am J Clin Oncol 15: 337–339

    Article  PubMed  CAS  Google Scholar 

  • Johnson GJ, Silvis SE, Roitman B et al. (1980) Long-term treatment of systemic mastocytosis with histamine H2 receptor antagonists. Am J Gastroenterol 74:485–489

    PubMed  CAS  Google Scholar 

  • Kamajian G, Felix J (1993) Acute mastocytosis: a potential dermatologic emergency. J Am Osteopath Assoc 93:792–796

    PubMed  CAS  Google Scholar 

  • Katoh N, Hirano S, Yasuno H (1996) Solitary mastocytoma treated with Tranilast. J Dermatol 23:335–339

    PubMed  CAS  Google Scholar 

  • Kettelhut BV, Metcalfe DD (1987) Plasma histamine concentration in evaluation of pediatric mastocytosis. J Ped 111: 419–421

    Article  CAS  Google Scholar 

  • Kettelhut BV, Metcalfe DD (1991) Pediatric mastocytosis. J Invest Dermatol 96:15S–18S

    Article  Google Scholar 

  • Kluin-Nellemans HC, Breukelmans JHJ, Wolthers BG et al. (1992) Response to interferon-alpha-2b in a patient with systemic mastocytosis. N Engl J Med 326: 619–623

    Article  Google Scholar 

  • Kolde G, Sunderkötter C, Luger TA (1995) Treatment of urticaria pigmentosa using interferon alpha. Br J Dermatol 133:91–94

    Article  PubMed  CAS  Google Scholar 

  • Kors JW, Doormaal JJ van, Monchy JG de (1993) Anaphylactoid shock following hymenoptera sting as a presenting symptom of systemic mastocytosis. J Int Med 233: 255–258

    Article  CAS  Google Scholar 

  • Kors JW, Doormaal JJ van, Breukelman H et al. (1996) Long-term follow-up of indolent mastocytosis in adults. J Int Med 239:157–164

    Article  CAS  Google Scholar 

  • Lazarus GS (1996) Mastocytosis: new understanding in cutaneous pathophysiology. J Dermatol 23:769–772

    PubMed  CAS  Google Scholar 

  • Lehmann T, Beyeler C, Lämmle B et al. (1996) Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2b. Br J Rheumatol 35: 898–900

    Article  PubMed  CAS  Google Scholar 

  • Longley BJ Jr, Morganroth GS, Tyrrell L et al. (1993) Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 328:1302–1307

    Article  PubMed  Google Scholar 

  • Luger TA (1995) Cytokine treatment of mast-cell mediated skin diseases. Exp Dermatol 4: 277–280

    Article  PubMed  CAS  Google Scholar 

  • Metcalfe DD (1991) The treatment of mastocytosis: an overview. J Invest Dermatol 96:55S–59S

    Article  Google Scholar 

  • Ogg GS, Rosbotham JL, Macdonald DM (1996) Urticaria pigmentosa coexisting with multiple myeloma. Clin Exp Dermatol 21:365–366

    Article  PubMed  CAS  Google Scholar 

  • Oranje AP, Soekanto W, Sukardi A et al. (1991) Diffuse cutaneous mastocytosis mimicking staphylococcal scalded-skin syndrome: report of three cases. Pediatr Dermatol 8: 147–151

    Article  PubMed  CAS  Google Scholar 

  • Parker RI (1991) Hematologic aspects of mastocytosis. II. Management of hematologic disorders in association with systemic mast cell disease. J Invest Dermatol 96: 52S–54S

    Article  Google Scholar 

  • Povoa P, Ducla-Soares J, Fernandes A, Palma-Carlos AG (1991) A case of systemic mastocytosis: therapeutic efficacy of ketotifen. J Int Med 229:475–477

    Article  CAS  Google Scholar 

  • Revert A, Jorda E, Ramon D et al. (1991) Xanthelasmoid mastocytosis. Pediatr Dermatol 8:152–154

    Article  PubMed  CAS  Google Scholar 

  • Shah PY, Sharma V, Worobec AS et al. (1998) Congenital bullous mastocytosis with myeloproliferative disorder and c-kit mutation. J Am Acad Dermatol 39:119–121

    Article  PubMed  CAS  Google Scholar 

  • Soter NA (1991) The skin in mastocytosis. J Invest Dermatol 96:32S–39S

    Article  Google Scholar 

  • Soter NA, Austen KF, Wasserman SI (1979) Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 301:465–469

    Article  PubMed  CAS  Google Scholar 

  • Stege H, Schöpf E, Ruzicka Th, Krutmann J (1997) High-dose UVA1 for urticaria pigmentosa. Lancet 347: 64

    Article  Google Scholar 

  • Stevens RL, Austen KF (1989) Processes with mast cell involvement. Immunol Today 10:381–386

    Article  PubMed  CAS  Google Scholar 

  • Tebbe B, Stavropoulos PG, Krasagakis K, Orfanos C E (1998) Cutaneous mastocytosis in adults. Dermatology 197: 101–108

    Article  PubMed  CAS  Google Scholar 

  • Topar G, Staudacher Ch, Geisen F et al. (1998) Urticaria pigmentosa. A clinical, hematopathologic and serologic study of 30 adults. Am J Clin Pathol 109: 279–285

    PubMed  CAS  Google Scholar 

  • Torrey E, Simpson K, Wilbur S et al. (1990) Malignant mastocytosis with circulating mast cells. Am J Hematol 34: 283–286

    Article  PubMed  CAS  Google Scholar 

  • Toyota N, Kitamura Y, Ogawa K (1990) Administration of 8-methoxypsoralen and ultraviolet A irradiation (PUVA) induces turnover of mast cells in the skin of C57BL/6 mice. J Invest Dermatol 95:353–358

    Article  PubMed  CAS  Google Scholar 

  • Travis WD, Li CY, Bergstralh (1989) Solid and hematologic malignancies in 60 patients with systemic mast cell disease. Arch Pathol Lab Med 113:365–368

    CAS  Google Scholar 

  • Väätäinen N, Hannuksela M, Karvonen J (1981) Trioxsalen baths plus UV-A in the treatment of lichen planus and urticaria pigmentosa. Clin Exp Dermatol 6:133–138

    Article  PubMed  Google Scholar 

  • Valent P (1996) Biology, classification and treatment of human mastocytosis. Wien Klin Wochenschr 108:385–397

    PubMed  CAS  Google Scholar 

  • Vaughan STA, Jones GN (1998) Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia. Anaesthesia 53:804–809

    Article  PubMed  CAS  Google Scholar 

  • Vella Briffa D, Eady RAJ, James MP et al. (1983) Photo-chemotherapy (PUVA) in the treatment of urticaria pigmentosa. Br J Dermatol 109: 67–75

    Article  PubMed  CAS  Google Scholar 

  • Welch EA, Alper JC, Bogaars H, Farrell DS (1983) Treatment of bullous mastocytosis with disodium cromoglycate. J Am Acad Dermatol 9:349–353

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie, Universitätsklinikum Benjamin Franklin Freie Universität Berlin, Fabeckstr. 60-62, 14195, Berlin, Deutschland

    Prof. Dr. Prof. h. c. Constantin E. Orfanos

  2. Hautklinik und Poliklinik, Eberhard-Karls-Universität, Liebermeisterstr. 25, 72076, Tübingen, Deutschland

    Prof. Dr. Claus Garbe

Authors
  1. Prof. Dr. Prof. h. c. Constantin E. Orfanos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. Claus Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

U. Blume-Peytavi C. C. Geilen S. Goerdt H. Gollnick E. Haneke F.-M. Köhn B. Tebbe R. Treudler Ch. C. Zouboulis

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Orfanos, C.E., Garbe, C. (2002). Mastzellkrankheiten. In: Blume-Peytavi, U., et al. Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56219-8_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56219-8_26

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62541-1

  • Online ISBN: 978-3-642-56219-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation